much recognition, even as an adjunct to arnylase activity. The main reasons are methodological. Several spectrophotometric (1) (2) (3) and nephelometric (4, 5) modifications of the lipase method have been reported, based on clearing of an oil emulsion (6) , which are fast and (theoretically) specific owing to the use of a "physiological" substrate. But incorrect activities in serum have been reported on use of this method: too-low or even negative photometric values (3, 7) , and toohigh nephelometric values (8, 9). Pope (9) called this phenomenon "pseudolipase" activity, a descriptive name we use here, too. As we have previously reported, pseudolipase activity seems to be commonly present in sera of patients with rheumatoid arthritis (10) and it correlates with the presence of rheumatoid factor in serum.
In the nephelometric method we use to determine lipase, we detect the presence of pseudolipase activity when a sample has to be diluted because its activity is otherwise too high; if there is pseudolipase in the serum, the measured lipase activity decreases more than would be expected from the dilution alone (11) . In a routine spectrophotometric measurement without a dilution step, the presence of pseudolipase is inferred only if the measured lipase activity is "negative." If pancreatic lipase activity is also increased, the effects may cancel each other and the activity may be within the reference range, or at least lower than the actual lipase activity. If no suitable method is available either for observing pseudolipase activity in a specimen or for eliminating it, the result may easily be invalid. We describe here a method for routine assay of serum lipase, in which any pseudolipase activity that is present is eliminated. assayed within one day after sampling.
Serum showing pseudolipase but not pancreatic lipase activity was prepared by incubating a specimen of pooled sera from rheumatoid patients at 60 #{176}C for 10 mm. Heat mactiyates pancreatic lipase but pseudolipase remains unaffected
(12).
Pancreatic lipase was obtained by collecting pancreatic fluid after cannulation of human pancreatic ducts and stored at -20 #{176}C. Pancreatic fluid was diluted with serum not containing pseudolipaseto given an activity of 2.5-3.0U/L. This was used throughout the study as a reference with known lipase activity.
Substrate.
Olive oil (Pharmaca Fennica VII, University
Pharmacy, Helsinki, Finland) was purified by allowing about 5 mL to flow through a column packed with aluminum oxide (height 1.5 cm in a disposable 10-mL syringe). The olive oil was dissolved in absolute ethanol to give a concentration of 8.0 g/L. The substrate was prepared by slowly pipetting 2.0 mL of this olive oil/alcohol solution into 100 mL of Tris buffer (per liter, 70 mmol of Tris HC1, pH 9.0,4.0 g of sodium deoxycholate, and 200 mg of sorbic acid) while mixing the solution continuously with a magnetic stirrer. This substrate emulsion is similar to the commercially available substrate for the
Coleman 91 Amylase-Lipase
Analyzer (Perkin-Elmer Corp., Oak Brook, IL 60521).
Apparatus.
Unless otherwise stated, concurrent measurements were made with a nephelometer (Coleman 91 Amylase-Lipase Analyzer) and a spectrophotometer with a lowvolume fiowthrough cuvette (Gilford Stasar III; Gilford Instrument Laboratories Inc., Oberlin, OH 44074). Responses were monitored with a two-channel recorder. The sensitivity of the nephelometer was adjusted with a standard according to the instructions for the instrument. The output of the spectrophotometer was adjusted so that the recorder showed a response equal to that with the nephelometer during the reaction with pancreatic lipase. In the spectrophotometer we used, a change of 0.2 A was equal to the whole scale of the nephelometer.
Procedures
We pipetted 3.3 mL of substrate into a nephelometer cuvette and incubated this for 20 mm at 37 #{176}C. A 0.55-zL sample of serum was then added and mixed, and 0.7-0.9 mL of the mixture was drawn into the flowthrough cuvette of the spectrophotometer.
Without delay, we placed the nephelometer cuvette in the measurement well of the nephelometer. The reactions were monitored at 340 nm for 6 mm, and lipase activities were based on measurements during the last 3 mm.
Lipase activities were determined according to the instructions for the nephelometer:
one arbitrary lipase unit is equal to (2.5/100) times the change per minute on the direct scale of the nephelometer, which corresponds to 0.005 A in the photometer we used. Values for lipase activity in the serum of healthy persons are <1.5 U/L.
When we investigated pseudolipase in sera, we found that pancreatic lipase is completely inhibited by benzeneboronic acid (Fluka AG, Buchs, Switzerland).
Aryl boronic acids in- hibit lipoprotem lipase (11) and porcine pancreatic lipase (12) . Before adding the sample, 110 iiL of benzeneboronic acid (20 g/L solution in water) was pipetted into a cuvette. Benzeneboronic acid had no effect on pseudolipase activity. The effect of dilution was insignificant (3.3%) and was therefore not taken into account. Serum was considered to contain pseudolipase if, after inhibition of pancreatic lipase, the measured activity differed from zero by 0.25 units or more. We measured micelle size in the substrate with a Coulter Channelyzer C-bOO (Coulter Electronics Ltd., South Dunstable, Beds., U.K.) with an aperture of 30 tm in the orifice tube. The substrate was diluted 50-fold with the Tris buffer, with added sodium chloride (35 g/L) to increaseconductivity. Sera were filtered through a membrane filter (av. pore size, 3.0 ftm) and all the other liquids through a 0.22-am (pore size) filter, both from Millipore Corp., Bedford, MA 01730. The volume measured was 50 L and the size distribution of particles was registered with a recorder.
We determined rheumatoid factor in serum by using the RF-Latex test (Behringwerke AG, Marburg, F.R.G.) without semiquantitative titration.
We also used latex particles coated with IgG (supplied with the RF-Latex test) to remove rheumatoid factor from the sera of patients with rheumatoid arthritis. We pipetted 300 zL of latex suspension into a 2-mL conical tube and centrifuged for 2 mm at 18 000 X g. The clear supernate was discarded, and 200 zL of serum was pipetted onto the latex sediment. The mixture was stirred, allowed to stand for 10 mm, then centrifuged for 3 mm at 18 000 X g.
Lipase activity was measured in the supernate as usual. In pretreating samples with 2-mercaptoethanol (Merck Co., Darmstadt, F.R.G.), we deviated from the recommendation of Pope (9), using two parts of serum and one part of 2-mercaptoethanol to obtain a finalconcentration of 40-120 ftmol of 2-mercaptoethanol per liter.
Serum IgG, IgA, and 1gM were quantified with a laserimmunonephelometric method (Behringwerke AG). Serum proteins were precipitated with polyethylene glycol (PEG 6000; BDH Chemicals Ltd., Poole, U.K.); two parts of serum and one part of PEG (90-375 g/L solution)
were pipetted into a 2-mL conical tube, mixed, allowed to stand for 5 mm, and then centrifuged for 2 mm at 18 000 X g. Lipase activity was measured in the supernate. The dilution effect was taken into account by using a 50% greater (i.e., 77.5 gL/3.3 mL) sample volume. This increase in sample volume had no effect on the measured pancreatic lipase activity. During daily measurements of lipase the following procedure was used to eliminate pseudolipase activity: 100 L of 165 g/L PEG is pipetted into 2-mL conical tubes, 200 1iL of the sample is added, and the mixture is allowed to stand and then centrifuged as specified above. The precipitate at the bottom of the tube is packed tightly and the supernate for the assay need not be separated. When the diluting factor is taken into account by using a sample volume of 1.5-fold the amount used before, the same instrument adjustments and factors can be used as earlier.
Results
We removed rheumatoid factor from sera of rheumatoid patients by using commercial latex particles coated with human IgG as described.
This process completely removed pseudolipase activity from all the sera that had contained rheumatoid factor according to the RF-Latex test. Some of the sera needed large dilutions before all pseudolipase was removed. When a serum showed pseudolipase activity but no demonstrable rheumatoid factor, latex treatment did not remove pseudolipase.
Latex treatment had no effect on pancreatic lipase activity.
We To study the effects of pancreatic lipase and pseudolipase on substrate, the change in particle size distribution of the substrate during the reaction was studied. The mode of size distribution of oil micelles in normal substrate
was 900 (SD 30) nm (n = 7). The micelles became smaller when pancreatic lipase reacted, whereas pseudolipase activity caused an increase in particle size (Figure 1 ). After a serum from a rheumatoid patient had reacted for 6 mm, 5 mL of the substrate was filtered through a 0.22-nm membrane filter. The filter was dried and stained with a protein dye (Coomassie Brilliant Blue in acetic acid/methanol/water). Pseudolipase caused a stainable protein precipitate on the filter. When a serum with no pseudolipase activity reacted, no stainable precipitate was observed. The disruptive effect of pseudolipase reportedly is removed by permitting the reaction to proceed further than normal (7), or by removing lipoproteins with dextran sulfate (7). Pretreatment of sera with 2-mercaptoethanol (100 mmol/L) for 6 mm has also been recommended (9) as a way to remove pseudolipase activity. We found that 2-mercaptoethanol destroys serum pseudolipase activity in sera from rheumatoid patients, but that the amount needed depends on the amount of rheumatoid factor in the serum; often a final concentration as low as 40 mmol/L had the required effect, whereas a concentration of 100 mmol/L sometimes had no effect, even after incubation for 30 mm. We also studied the effect of 2-mercaptoethanol on pancreatic lipase and found that incubation with 2-mercaptoethanol (100 mmol/L) decreased lipase activity with increasing time (Figure 2) . We analyzed 95 sera for which the RF-Latex test was positive, to get an idea of the incidence of pseudolipase among rheumatoid patients.
In 88 (93%) there was demonstrable pseudolipase activity. The diagnoses of a further 30 patients who were found to have pseudolipase activity in their sera were: rheumatoid arthritis in 15, kidney diseases of various etiology in seven, LED in five, diabetes mellitus in two, and acute myocardial infarction in one patient.
To investigate the incidence of pseudolipase activity in the sera of outpatient and hospitalized patients, we analyzed sera from 88 randomly selected patients. Sera from 28 of these patients were measured both with the spectrophotometer and with the nephelometer, the rest only with the nephelometer. Pseudolipase activity was found in 24 (27%) of the sera. In most cases pseudolipase activities were fairly low, and six specimens (7%) gave values exceeding the reference interval for serum lipase as measured with the nephelometer. Pseudolipase activity was demonstrable in 17 specimens measured with the spectrophotometer.
The response as measured in the native sample was negative in seven specimens, i.e., pseudolipase activity canceled pancreatic lipase activity. We also found that the result of the measurement depended on the geometry of the cuvette used (13) . Some of the samples with pseudolipase activity were analyzed with another photometer in which round, thermostatically controlled, disposable cuvettes are used. The response was positive in most of the samples that had given negative response with Gilford Stasar III photometer.
The significance of pseudolipase as a factor disrupting turbidimetric measurements of lipase thus also depends on the instrument used.
We also attempted to inhibit serum pseudolipase activity in patients ' samples by using a final PEG concentration of 55 g/L. In sera with no pseudolipase activity the precipitation of 
Discussion
Measurement of lipase activity turbidimetrically or nephelometricallyisfasterand easier than by titrimetry (14, 15) and theoretically more specific than by colorimetry or fluorometry with nonphysiological substrates (16, 17) . The method is, however, affected by any aggregation of the sample components with the substrate or by other changes in turbidity. Suggestions as to the cause of pseudolipase activity include an interaction between serum lipoproteins and deoxycholate in the substrate (8), in which oil micelles may also play a role (9) . In the light of our results it seems probable that serum immunoglobulins of the 1gM class-rheumatoid factor as a typical example-play a central role in pseudolmpase activity. This is supported by the observation that samples with high pseudolipase activities also usually had higher 1gM concentrations.
We found sera with very high concentrations of 1gM but with no pseudolipase activity, as well as sera with pseudolipase activity and low IgM concentrations. Perhaps the 1gM molecule has a special structure or circulates as a special immune complex before it causes pseudolipase activity. Immunoglobulins probably aggregate with lipid micelles, as shown by the fact that during the reaction of a rheumatoid serum the number of small particles in the substrate decreases ( Figure  1 ) and large particles containing protein are formed. Pseudolipase activity has certain similarities to the old cephalincholesterol test that demonstrated the presence of "abnormal hepatic gamma-globulins" in serum (18 (20) . With the PEG concentration used for the precipitation of proteins in patients' sera in the present study, the disruptive factors were completely sedimented but lipase activity remained in the supernate. Lipase collected from pancreatic duct and diluted with saline or bovine serum albumin solution was not inhibited by any concentration of PEG, nor was there any protein precipitation.
In contrast, lipase activity in serum decreased after treatment with 100 g of PEG per liter or more. This may be due to a co-precipitation of lipase with other proteins.
Infections and diseases that may cause active immune responses are fairly common among hospitalized patients. Thus it is understandable that pseudolipase activity may disrupt turbidimetric and nephelometric measurements of lipase more often than has been thought. In most sera containing pseudolipase, its activities are so low that they are not observed in routine lipase measurements; the situation becomes clinically important, however, if weak pseudolipase activity in a specimen increases or decreases a lipase activity that is near the reference limit, thus giving a false-negative result with the spectrophotometer or a false-positive one with the nephelometer.
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